These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1603336)
21. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors. Vasar E; Stephenson JD; Meldrum BS Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160 [TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro. Saleh TM; Kombian SB; Zidichouski JA; Pittman QJ Neuroscience; 1997 Mar; 77(1):23-35. PubMed ID: 9044371 [TBL] [Abstract][Full Text] [Related]
23. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide. Boyle SJ; Tang KW; Woodruff GN; McKnight AT Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944 [TBL] [Abstract][Full Text] [Related]
24. Excitatory and inhibitory synaptic processing in the accessory olfactory system of the female rat. Wong M; Chen Y; Moss RL Neuroscience; 1993 Sep; 56(2):355-65. PubMed ID: 8247266 [TBL] [Abstract][Full Text] [Related]
25. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study. Morency MA; Quirion R; Mishra RK Neuroscience; 1994 Sep; 62(1):307-16. PubMed ID: 7816208 [TBL] [Abstract][Full Text] [Related]
26. Differential expression of Fos protein in the brain of female mice dependent on pup sensory cues and maternal experience. Calamandrei G; Keverne EB Behav Neurosci; 1994 Feb; 108(1):113-20. PubMed ID: 8192837 [TBL] [Abstract][Full Text] [Related]
27. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons. Kelland MD; Zhang J; Chiodo LA; Freeman AS Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334 [TBL] [Abstract][Full Text] [Related]
28. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion. Luckman SM; Hamamura M; Antonijevic I; Dye S; Leng G Br J Pharmacol; 1993 Sep; 110(1):378-84. PubMed ID: 8220899 [TBL] [Abstract][Full Text] [Related]
29. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. O'Neill MF; Dourish CT; Iversen SD Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197 [TBL] [Abstract][Full Text] [Related]
30. Localization of oestrogen receptors in preoptic neurons containing neurotensin but not tyrosine hydroxylase, cholecystokinin or luteinizing hormone-releasing hormone in the male and female rat. Herbison AE; Theodosis DT Neuroscience; 1992 Sep; 50(2):283-98. PubMed ID: 1359459 [TBL] [Abstract][Full Text] [Related]
31. Central forebrain Fos responses to familiar male odours are attenuated in recently mated female mice. Halem HA; Cherry JA; Baum MJ Eur J Neurosci; 2001 Jan; 13(2):389-99. PubMed ID: 11168544 [TBL] [Abstract][Full Text] [Related]
32. Selective effects of beta-endorphin infused into the hypothalamus, preoptic area and bed nucleus of the stria terminalis on the sexual and ingestive behaviour of male rats. Hughes AM; Everitt BJ; Herbert J Neuroscience; 1987 Dec; 23(3):1063-73. PubMed ID: 2830562 [TBL] [Abstract][Full Text] [Related]
33. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat. Rodríguez-Membrilla A; Martínez V; Vergara P J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590 [TBL] [Abstract][Full Text] [Related]
34. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Boden PR; Woodruff GN; Pinnock RD Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831 [TBL] [Abstract][Full Text] [Related]
35. Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide. Higgins GA; Nguyen P; Sellers EM Eur J Pharmacol; 1991 May; 197(2-3):229-30. PubMed ID: 1915570 [No Abstract] [Full Text] [Related]
36. Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas. He X; Nelson MT; Debas HT Chin Med Sci J; 1996 Mar; 11(1):32-5. PubMed ID: 9206116 [TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137 [TBL] [Abstract][Full Text] [Related]
38. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin. Altar CA; Boyar WC Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523 [TBL] [Abstract][Full Text] [Related]
39. Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system. Hernando F; Fuentes JA; Fournié-Zaluski MC; Roques BP; Ruiz-Gayo M Eur J Pharmacol; 1996 Dec; 318(2-3):221-9. PubMed ID: 9016909 [TBL] [Abstract][Full Text] [Related]
40. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats. Wu CL; Doong ML; Wang PS Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]